Ucb S.A.
UCB S.A., a global biopharmaceutical company headquartered in Brussels, Belgium, is renowned for its innovative approach in the fields of neurology and immunology. Founded in 1928, UCB has achieved significant milestones, including the development of groundbreaking therapies that address complex diseases.
With a strong presence in Europe and North America, UCB focuses on delivering unique solutions such as monoclonal antibodies and small molecules, which set them apart in the competitive biopharmaceutical landscape. Their commitment to research and development has positioned UCB as a leader in the industry, with notable achievements in improving the quality of life for patients with severe conditions.
UCB's dedication to scientific excellence and patient-centric solutions underscores its reputation as a trusted name in biopharmaceuticals.
+45 vs industry average
Ucb S.A.’s score of 83 is higher than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Ucb S.A.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Ucb S.A. yet.
Ucb S.A.'s reported carbon emissions
Ucb S.A., headquartered in Greece, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of UCB SA, and any relevant emissions data or climate commitments may be cascaded from this parent organization.
Ucb S.A. has not outlined specific reduction targets or initiatives in its climate strategy, nor does it appear to have made any formal climate pledges. The lack of documented reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate action plan.
As a subsidiary, Ucb S.A. may align its climate commitments with those of UCB SA, which could include adherence to industry standards and frameworks such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). However, without specific data or commitments from Ucb S.A., it is challenging to provide a detailed overview of its carbon emissions and climate commitments.
In summary, Ucb S.A. currently lacks publicly available emissions data and defined climate commitments, reflecting a potential area for future development in sustainability practices.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Ucb S.A.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Ucb S.A. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from UCB SA
Carbon Disclosure Project
Inherited from UCB SA
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project